Aerovate Therapeutics Inc...
(AVTE)
undefined
undefined%
At close: undefined
2.68
0.19%
After-hours Jan 03, 2025, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Revenue | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 96.00K | 68.00K | 15.00K | 1K | n/a |
| Gross Profit | -96.00K | -68.00K | -15.00K | -1K | n/a |
| Operating Income | -81.41M | -53.24M | -23.02M | -8.89M | -3.33M |
| Interest Income | 5.95M | 1.83M | 65.00K | 75.00 | n/a |
| Pretax Income | -75.47M | -51.49M | -22.96M | -9.61M | -3.33M |
| Net Income | -75.52M | -51.51M | -22.96M | -9.04M | -3.33M |
| Selling & General & Admin | 17.19M | 14.62M | 8.04M | 949.00K | 218.00K |
| Research & Development | 64.22M | 38.62M | 14.99M | 7.94M | 3.11M |
| Other Expenses | 0.00 | -79.00K | -3.00K | -647.00K | 1K |
| Operating Expenses | 81.41M | 53.24M | 23.02M | 8.89M | 3.33M |
| Interest Expense | n/a | n/a | 65.00K | 75.00K | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 81.41M | 53.24M | 23.02M | 8.89M | 3.33M |
| Income Tax | 56.00K | 25.00K | 3.00K | -572.00K | 1K |
| Shares Outstanding (Basic) | 26.33M | 24.47M | 24.41M | 24.41M | 24.41M |
| Shares Outstanding (Diluted) | 26.33M | 24.47M | 24.41M | 24.41M | 24.41M |
| EPS (Basic) | -2.87 | -2.1 | -0.94 | -0.37 | -0.14 |
| EPS (Diluted) | -2.87 | -2.1 | -0.94 | -0.37 | -0.14 |
| EBITDA | -81.31M | -53.17M | -23.01M | -8.89M | 1K |
| Depreciation & Amortization | 96.00K | 68.00K | 15.00K | 1K | 3.33M |